The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae

Drug Design, Development and Therapy

Volumn 8, Issue , 2014, Pages 1733-1743

  Yayan, Josef ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Antimicrobial therapy; Drug resistant antibiotics; Drug resistant Streptococcus pneumoniae; Penicillin resistance; Pneumococcal pneumonia

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GYRASE INHIBITOR; LINCOSAMIDE; MACROLIDE; MEROPENEM; NITROFURAN DERIVATIVE; OXAZOLIDINONE DERIVATIVE; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; RIFAMPICIN; STREPTOCOCCUS ANTIGEN; STREPTOGRAMIN DERIVATIVE; SULTAMICILLIN; TAZOBACTAM; TETRACYCLINE; UNINDEXED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CLINICAL ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; COMPARATIVE STUDY; FEMALE; HUMAN; LUNG ASPIRATION; LUNG LAVAGE; MALE; NONHUMAN; PNEUMOCOCCAL INFECTION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; URINALYSIS; COMMUNITY-ACQUIRED INFECTIONS; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; RETROSPECTIVE STUDY; STREPTOCOCCAL INFECTIONS;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MACROLIDES; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; RETROSPECTIVE STUDIES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 84908071701     PISSN: 11778881     EISSN: 11778881     Source Type: Journal    
DOI: 10.2147/DDDT.S71349     Document Type: Article

References (21)

1. British Thoracic Society Standards of Care Committee. BTS guidelines for the management of community acquired pneumonia in adults. Thorax. 2001;56(4):1-64.
2. Scott SS, Kardos CB. Community-acquired, health care-associated, and ventilar-associated pneumonia: three variations of a serious disease. Crit Care Nurs Clin North Am. 2012;24:431-441.
3. Kleinpell RM, Elpern EH. Community-acquired pneumonia: updates in assessment and management. Crit Care Nurs Q. 2004;27:231-240.
4. Beekmann SE, Heilmann KP, Richter SS, et al. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program. Int J Antimicrob Agents. 2005;25:148-156.
5. Kattan R, Abu Rayyan A, Zheiman I, et al. Serotype distribution and drug resistance in Streptococcus pneumoniae. Emerg Infect Dis. 2011;17:94-96.
6. International Organization for Standards. Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility testing devices. 1. Reference method for testing the in vitro activity of antimicrobial agents against rapidly growing anaerobic bacteria involved in infectious diseases. ISO 20776-1. Geneva, Switzerland: International Organization for Standards; 2006. Available from: http://www.iso.org/iso/iso_catalogue/catalogue_tc/catalogue_detail.htm?csnumber=41630. Accessed July 17, 2014.
7. Imähl M, van der Linden M. [Invasive pneumococcal disease in Germany in the era of pneumococcal conjugate vaccination]. Dtsch Med Wochenschr. 2014;139:1346-1351. German.
8. National Reference Center for Streptococci, Institute of Medical Microbiology, University Hospital RWTH Aachen. 2012. Available from: http://www.pneumococcus.de/. Accessed July 17, 2014.
9. Dylewski J, Davidson R. Bacteremic pneumococcal pneumonia associated with macrolide failure. Eur J Clin Microbiol Infect Dis. 2006; 25:39-42.
10. Rzeszutek M, Wierzbowski A, Hoban DJ, Conly J, Bishai W, Zhanel GG. A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae. Int J Antimicrob Agents. 2004;24:95-104.
11. Aspa J, Rajas O, de Castro FR. Pneumococcal antimicrobial resistance: therapeutic strategy and management in community-acquired pneumonia. Expert Opin Pharmacother. 2008;9:229-241.
12. Metzler K, Drilica K, Blondeau JM. Minimal inhibitory and mutant prevention concentrations of azithromycin, clarithromycin and erythromycin for clinical isolates of Streptococcus pneumoniae. J Antimicrob Chemother. 2013;68:631-635.
13. Schito GC, Felmingham D. Susceptibility of Streptococcus pneumoniae to penicillin, azithromycin and telithromycin (PROTEKT 1999-2003). Int J Antimicrob Agents. 2005;26:479-485.
14. Marchese A, Gualco L, Cochetti I, et al. Antibiotic susceptibility and serotype distribution in Streptococcus pneumoniae circulating in Italy: results of the SEMPRE surveillance study (2000-2002). Int J Antimicrob Agents. 2005;26:138-145.
15. Kang CI, Song JH, Kim SH, et al. Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study Group. Association of levofloxacin resistance with mortality in adult patients with invasive pneumococcal diseases: a post hoc analysis of a prospective cohort. Infection. 2013;41:151-157.
16. Carlavilla AB, López-Medrano F, Chaves F, Villena V, Echave-Sustaeta J, Aguado JM. [Failure of levofloxacin therapy in two cases of community-acquired pneumonia caused by fluoroquinolone-resistant Streptococcus pneumoniae and complicated with empyema]. Enferm Infecc Microbiol Clin. 2005;23:270-273. Spanish.
17. Reinert RR, Reinert S, van der Linden M, Cil MY, Al-Lahham A, Appelbaum P. Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003. Antimicrob Agents Chemother. 2005;49:2903-2913.
18. WHO. HIV/AIDS Guidelines. Available from: http://www.who.int/hiv/pub/guidelines/en/. Accessed July 17, 2014.
19. Hofmann J, Cetron MS, Farley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med. 1995;333:481-486.
20. Deva A, Prasad SR, Madappa BP, Junjegowda K, Bachu RP. Pneumococcal infections at a rural tertiary care hospital: a seven year study on isolation rate, clinical spectrum and antibiogram. J Clin Diag Res. 2014;8:50-52.
21. Johansson N, Kalin M, Giske CG, Hedlund J. Quantitative detection of Streptococcus pneumoniae from sputum samples with real-time quantitative polymerase chain reaction for etiologic diagnosis of community-acquired pneumonia. Diagn Microbiol Infect Dis. 2008;60:255-261.